Medicine and Dentistry
Combination Therapy
100%
Patient
85%
Medroxyprogesterone Acetate
42%
Therapeutic Procedure
42%
Oncology
42%
Chemotherapy
28%
Side Effect
28%
Interferon
28%
Immunoglobulin
28%
Kidney Metastasis
28%
Vinblastine
28%
Survival
28%
In Vitro
14%
Toxicity
14%
Neoplasm
14%
Gene Expression
14%
Surgery
14%
Lymph Node
14%
Primary Tumor
14%
Outpatient
14%
Distant Metastasis
14%
Lymph Node Metastasis
14%
Indicator
14%
Clear Cell Renal Cell Carcinoma
14%
Age
14%
Radical Nephrectomy
14%
Lung Lobectomy
14%
Renal Cell Carcinoma Cell Line
14%
Base
14%
Male
14%
Female
14%
Kidney
14%
Lung
14%
Liver
14%
Bone
14%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
85%
Medroxyprogesterone Acetate
42%
Interferon
28%
Immunoglobulin
28%
Side Effect
28%
Kidney Metastasis
28%
Vinblastine
28%
Survival
28%
Neoplasm
14%
Toxicity
14%
Indicator
14%
Primary Tumor
14%
Distant Metastasis
14%
Lymph Node Metastasis
14%
Base
14%
Death
14%